Priority setting for orphan drugs: An international comparison
-
Gene Associated with ALS identified ! – Courtesy(Patent Docs)
Pharma Live, , Intellectual Property Rights, 0
One of the promises of the Human Genome Project was that knowledge of the entirety of the human genetic...
-
The Nasty Patent Games Drug Companies Play To Stop You From Getting Cheaper Drugs – Courtesy (TechDirt)
Pharma Live, , Intellectual Property Rights, 0
The astoundingly wonderful radio program/podcast Radiolab just recently had an episode called“Worth” — which included a few different stories trying...
-
The Importance of Contracts for Joint Infringement in Patent Cases – Courtesy (IP Litigation Current)
Pharma Live, , Intellectual Property Rights, 0
POSTED BY JUSTIN M. SOBAJE ON 19 MAY 2015POSTED IN DIVIDED INFRINGEMENT;DIVIDED INFRINGEMENT;PATENTS;PLEADINGS;SUPREME COURTIt has been about a year since the Supreme...
-
Evergreening, patent challenges, and effective market life in pharmaceuticals
Pharma Live, , Intellectual Property Rights, 0
1-s2-0-s0167629612000057-mainDownload
-
Novo Nordisk rejects Baxter patent claim over Novoeight
Pharma Live, , Intellectual Property Rights, 0
COPENHAGEN, May 20 (Reuters) – Novo Nordisk said on Wednesday it rejected claims by U.S. rival Baxter International that...
-
GW Pharmaceuticals Announces Us Patent Allowance For Use Of Cannabidivarin (CBDV) In Treating Epilepsy – Courtesy( Biospace)
Pharma Live, , Intellectual Property Rights, 0
GW Pharmaceuticals plc (AIM:GWP) (Nasdaq:GWPH) (“GW”) announced that the United States Patent and Trademark Office (USPTO) has issued a...
-
Orexigen and Takeda Feud Over Cost of a Controversial Diet Drug Trial – Courtesy (Pharmalot)
Pharma Live, , Intellectual Property Rights, 0
The controversy surrounding Orexigen Therapeutics OREX -0.20% and its release of interim study data for its Contrave diet pill...
-
FDA Releases Draft Guidance on Biosimilars
Pharma Live, , Intellectual Property Rights, 0
POSTED BY COURTENAY C. BRINCKERHOFF ON 9 FEBRUARY 2012POSTED IN BIOSIMILARSOn February 9, 2012, the FDA issued long-awaited (draft) guidance documents on...